---
title: "Pioglitazone - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: pioglitazonediabetesmellitustype22.html
toc: false 
---

{% include image.html file="pioglitazonediabetesmellitustype22.png" alt="pioglitazonediabetesmellitustype22" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB01132 | Pioglitazone | Drug |
| UniProt:P37231 | peroxisome proliferator-activated receptor-gamma | Protein |
| REACT:R-HSA-70263 | gluconeogenesis | Pathway |
| GO:0001951 | uptake of blood glucose | BiologicalProcess |
| MESH:D001786 | blood glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pioglitazone | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor-Gamma |
| Peroxisome Proliferator-Activated Receptor-Gamma | NEGATIVELY REGULATES | Gluconeogenesis |
| Gluconeogenesis | INCREASES RESPONSE TO | Uptake Of Blood Glucose |
| Uptake Of Blood Glucose | DECREASES ABUNDANCE OF | Blood Glucose |
| Blood Glucose | CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01132#mechanism-of-action](https://go.drugbank.com/drugs/DB01132#mechanism-of-action){:target="_blank"}